Sweden · Delayed Price · Currency is SEK AcouSort AB Company Description
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples.
The company has collaboration agreement with global life science company to develop cell therapy and other elements of the future automated systems.
AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
| Country | Sweden |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Torsten Freltoft |
Contact Details
Address: Building 406 Lund, 223 81 Sweden | |
| Phone | 46 45 20 45 08 54 |
| Website | acousort.com |
Stock Details
| Ticker Symbol | ACOU |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009189608 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Torsten Freltoft M.Sc., Ph.D. | Chief Executive Officer |
| Prof. Thomas Laurell Ph.D. | Founder and Independent Director |
| Dr. Stefan Scheding M.D. | Founder and Independent Director |
| Prof. Patrik Brundin M.D., Ph.D. | Founder |
| Dr. Hans Lilja | Founder |
| Gunnar Telhammar | Chief Financial Officer |
| Henrik Johansson Ph.D. | Director of Research and Technology |